Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Vast Therapeutics
3121
Vast Therapeutics
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Therapeutics
Novoclem develops inhalable treatments for antibioticresistant pathogens present in cystic fibrosis and other respiratory disease patients. Anne Whitaker is set to complete preclinical stage of development.
Suggest edits
Raised
$15M
Follow us
Companies in the same industry
PeptiMimesis
Fulgent Diagnostics
DelMar Pharma
Verona Pharma Plc
Lumobiotics
IMMT - Institute of Metagenomics...
Methylation Sciences
Myonexus Therapeutics, Inc.
Ventus Therapeutics
Neos Therapeutics, Inc.
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Add round
15 Jan
2019
$15,000,000
Venture capital (Series A)
Cystic Fibrosis Foundation
,
Shionogi
